Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy
The Oncologist · 2024
DOI: 10.1093/oncolo/oyae190 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2024. Verfasst von Xin Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto ON, Canada. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Palliative Care, Stomach Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The incidence of esophageal and gastric carcinoma (GEC) in elderly patients is increasing, yet patients ≥75 years have historically been underrepresented in clinical trials. We sought to investigate palliative chemotherapy administration patterns and survival outcomes in older adults. Materials and Methods A retrospective analysis identified patients aged 65-74 (young-old) and ≥75 years (older-old) diagnosed with advanced GEC. Patient and tumor characteristics were recorded, with descriptive analysis, time-to-event data analysis using Kaplan-Meier curves and multivariate Cox proportional hazards regression analysis performed.
Results
One hundred and ninety-eight “young-old” and 109 ‘older-old’ patients were identified. Patient characteristics were similar between groups except for Charlson Co-morbidity Index (CCI), with lower co-morbidities in the “young-old” compared to “older-old” cohort (P < .001; CCI = 0 in 103 (52%) “young-old” vs 31 (28%) “older-old”). The primary diagnosis in both groups was adenocarcinoma. 119 (60%) “young-old” and 25 (23%) “older-old” patients received chemotherapy (P < .001). Performance status was the primary explanation for chemotherapy non-receipt in both cohorts; age was the explanation in 21 (25%) “older-old” patients and none in the “young-old” patients. PFS for first-line systemic therapy in “young-old” patients was 6.4 (95% CI 5.9-7.6) versus 7.5 months (95% CI 5.1-11.3) in “older-old” patients (P = .69) whilst respective OS was 12.3 (95% CI 10.1-15.5) and 10.4 months (95% CI 9.0-14.6) (P = .0816). Toxicity prompted chemotherapy cessation in 17 (15%) “young-old” and 3 (13%) “older-old” patients (P = .97). Multivariate analysis identified CCI and ECOG performance status as predictive for PFS and OS, respectively. No causative relationship was identified with other variables.
Conclusion
Our study of real-world older-adults show that significant number of “older-old” patients with GEC do not receive chemotherapy. Among “older-old” adults who do receive systemic therapy, outcomes are comparable; this underscores the importance of geriatric assessment-guided care and suggests that age alone should not be a barrier to receipt of chemotherapy in patients with advanced GEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto ON, Canada.
- Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
- Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
- Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
- Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada.
- Division of Pathology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
ORCID-Profile: Xin Wang, Michael J Allen, Jonathan Yeung
Zitieren
APA
Wang, X., Allen, M. J., Espin-Garcia, O., Suzuiki, C., Bach, Y., Panov, E., Ma, L. X., Jang, R. W., Chen, E. X., Darling, G. E., Yeung, J., Swallow, C. J., Brar, S. S., Kalimuthu, S., Wong, R., Veit-Haibach, P., & Elimova, E. (2024). Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy. The Oncologist. https://doi.org/10.1093/oncolo/oyae190
Vancouver
Wang X, Allen MJ, Espin-Garcia O, Suzuiki C, Bach Y, Panov E, et al. Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy. The Oncologist. 2024. doi:10.1093/oncolo/oyae190
BibTeX
@article{Wang2024,
author = {Wang, Xin and Allen, Michael J and Espin-Garcia, Osvaldo and Suzuiki, Chihiro and Bach, Yvonne and Panov, Elan and Ma, Lucy X and Jang, Raymond W and Chen, Eric X and Darling, Gail E and Yeung, Jonathan and Swallow, Carol J and Brar, Savtaj Singh and Kalimuthu, Sangeetha and Wong, Rebecca and Veit-Haibach, Patrick and Elimova, Elena},
title = {Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy},
journal = {The Oncologist},
year = {2024},
doi = {10.1093/oncolo/oyae190}
}
EUVIMED